Attenuation of a rocuronium‐induced neuromuscular block in patients receiving prednisolone

Abstract

Prednisolone treatment in patients with inflammatory bowel disease is associated with a delayed onset and a shorter duration of action of rocuronium. The presence of an inflammatory bowel disease did not influence the neuromuscular block.